Stock 600385 SHANDONG JINTAI GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Shandong Jintai Group Co., Ltd.

Equities

600385

CNE0000018K3

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Shandong Jintai Group Co., Ltd. cancelled the transaction announced on March 4, 2021
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Shandong Jintai Group Co., Ltd. Auditor Raises 'Going Concern' Doubt
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
CI
Shandong Jintai Group Co., Ltd. announced that it expects to receive CNY 155.956825 million in funding from Beijing Towercrest Investment Management Group Co., Ltd
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
CI
Shandong Jintai Group Co., Ltd. Provides Earnings Guidance for the Year 2019
CI
Shandong Jintai Group Co., Ltd. completed the acquisition of Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd.
CI
Jinan Jintai Pharmaceutical Technology Development Co., Ltd. announced that it expects to receive $12 million in funding from Shandong Jintai Group Co., Ltd.
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2019
CI
Shandong Jintai Group Co., Ltd. signed the share acquisition framework agreement to acquire Jinan Jinda Pharmaceutical Chemical Co., Ltd. from Beijing Towercrest Investment Management Group Co., Ltd. for CNY 80 million.
CI
Shandong Jintai Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019
CI
Shandong Jintai Group Co., Ltd. cancelled the acquisition of Fujian Meinkind Baby Products Co., Ltd. from 18 shareholders.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600385 Stock
  4. News Shandong Jintai Group Co., Ltd.